nordy

08/01/2008 - "The results suggested that Nordy might be a potential tumor therapeutic agent."
09/01/2007 - "Nordy suppressed both the proliferation of U87MG cells in vitro and the tumor growth of orthotopic transplanted tumors in vivo (P < 0.01). "
09/01/2007 - "Thus, Nordy may constitute a molecular basis for the development of novel anti-cancer drugs."
01/01/2016 - "Ultrasonic microbubbles can be used as the carrier of Nordy and achieve its targeted release with improved anti-tumor efficacy in the condition of ultrasound-induced microbubbles destruction."
01/01/2016 - "The ultrasound-induced Nordy-loaded microbubbles destruction inhibited the proliferations of HUVECs and Td-ECs in vitro, and inhibited the tumor growth and the microvasculature in vivo. "

02/01/2008 - "In this study, we found that Nordy inhibited the growth of human glioma cell lines in vitro and their tumorigenicity in mice. "
02/01/2008 - "In addition, Nordy promoted differentiation of highly malignant human glioma cells. "
03/01/2007 - "[Effect of nordy on FPR function of malignant human glioma cell line U87]."
03/01/2007 - "Nordy could inhibit FPR functioning in glioma cell proliferation, migration and angiogenesis, which might be a possible mechanism of its anti-cancer effects."
04/21/2006 - "Our results suggest that Nordy was capable of reducing the level of malignancy of glioma cells."

08/01/2007 - "Further study revealed that the effect of Nordy was attributable to its down-regulation of the expression of functional CXCR4 in glioblastoma cells. "
08/01/2007 - "In this study we examined the capacity of Nordy to regulate CXCR4-mediated production of angiogenic factors by human glioblastoma cells. "
10/01/2017 - "Regardless of the structural similarity, NDGA-P21 exhibited stronger capability in suppression of glioblastoma (GBM) cell growth as compared to Nordy. "
09/01/2007 - "Nordy promotes the differentiation of glioblastoma cells, by which it may serve as a therapeutic agent. "
09/01/2007 - "Glioblastoma U87MG cells were induced to differentiate by synthetic lipoxygenase inhibitor, Nordy. "

06/01/2011 - "We found that Nordy inhibited an enzyme known to be involved in leukemia stem cell and leukemia progression, Alox-5, and attenuated the growth of GSLCs in vitro. "

10/01/2017 - "Nordihydroguaiaretic acid (NDGA) and its synthetic chiral analog dl-nordihydroguaiaretic acid (Nordy) show collective benefits in anti-tumor, and defending against viral and bacterial infections. "